Publication | Closed Access

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

HepatologyMedicineLiver PhysiologyPathologyPlacebo-controlled TrialNon-alcoholic SteatohepatitisLiver DiseaseFatty Liver DiseasePharmacologyDigestive System Diseases